In the world of modern diagnostics, early and accurate detection of disease is everything. But to detect illness before symptoms appear or to monitor subtle changes in treatment response we need tools capable of sensing the tiniest biological signals. This is where ultra-sensitive biomarker detection comes into play.
Biomarkers are molecules such as proteins, nucleic acids, or metabolites that serve as measurable indicators of biological processes or diseases. For example, elevated levels of a protein like troponin can signal heart damage, while specific gene mutations can indicate cancer risks.
Detecting these biomarkers, especially at very low concentrations (picomolar or even femtomolar levels), can help clinicians:
Diagnose diseases at earlier stages
Personalize treatments
Track disease progression with more precision
Ultra-sensitive detection methods go far beyond traditional tests. They often rely on advanced technologies such as:
By improving sensitivity and precision, these technologies are not only reshaping diagnostics but opening new frontiers in early intervention, personalized medicine, and disease monitoring.
At Aligned Bio, our mission is to deliver next-generation nanowire platforms that make ultra-sensitive, scalable detection a clinical reality.